Charles Schwab Investment Management Inc Charles River Laboratories International, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 515,222 shares of CRL stock, worth $97.7 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
515,222
Previous 482,911
6.69%
Holding current value
$97.7 Million
Previous $99.8 Million
1.74%
% of portfolio
0.02%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$964 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$709 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$404 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$368 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.64B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...